TD Cowen Upgrades Cardinal Health(CAH.US) to Buy Rating, Raises Target Price to $144

TD Cowen上調卡地納健康(CAH.US)至買入評級，上調目標價至144美元

moomoo資訊 · 01/08 19:31 · 評級/大行評級

TD Cowen analyst Charles Rhyee upgrades $Cardinal Health (CAH.US)$ to a buy rating, and adjusts the target price from $130 to $144.

According to TipRanks data, the analyst has a success rate of 46.5% and a total average return of 1.4% over the past year.

AnalystRecentRatingAutoNews_201932_20250108_b0a104bb9219c6978a891da788836c373f59131f_1736418801032447_mm_en

Furthermore, according to the comprehensive report, the opinions of $Cardinal Health (CAH.US)$'s main analysts recently are as follows:

New customer onboarding, robust utilization trends, and recent ventures into specialty services are likely to propel Cardinal Health's adjusted earnings to surpass current expectations and achieve growth in its Pharma segment beyond the 4%-6% long-term target.
The estimate of 4-6% growth in adjusted operating income for the pharmaceutical sector is considered conservative, with expectations for further growth in long-term forecasts. The predictions suggest an increase in earnings per share for FY25 and a resumption of the historical 12%-14% compound annual growth rate by FY26.

Note:

TipRanks, an independent third party, provides analysis data from financial analysts and calculates the Average Returns and Success Rates of the analysts' recommendations. The information presented is not an investment recommendation and is intended for informational purposes only.

Success rate is the number of the analyst's successful ratings, divided by his/her total number of ratings over the past year. A successful rating is one based on if TipRanks' virtual portfolio earned a positive return from the stock. Total average return is the average rate of return that the TipRanks' virtual portfolio has earned over the past year. These portfolios are established based on the analyst's preliminary rating and are adjusted according to the changes in the rating.

TipRanks provides a ranking of each analyst up to 5 stars, which is representative of all recommendations from the analyst. An analyst's past performance is evaluated on a scale of 1 to 5 stars, with more stars indicating better performance. The star level is determined by his/her total success rate and average return.

TD Cowen分析師Charles Rhyee上調$卡地納健康 (CAH.US)$至買入評級，並將目標價從130美元上調至144美元。

根據TipRanks數據顯示，該分析師近一年總勝率為46.5%，總平均回報率為1.4%。

AnalystRecentRatingAutoNews_201932_20250108_b0a104bb9219c6978a891da788836c373f59131f_1736418801032447_mm_tc

此外，綜合報道，$卡地納健康 (CAH.US)$近期主要分析師觀點如下：

新客戶的加入、強勁的利用率趨勢以及最近在專業服務領域的投資可能會推動Cardinal Health調整後的收益超過當前的預期，使其製藥板塊的增長超過4％-6％的長期目標。
製藥行業調整後營業收入增長4-6％的估計被認爲是保守的，長期預測預計將進一步增長。預測表明，25財年的每股收益將增加，到26財年，將恢復歷史上12％-14％的複合年增長率。

提示:

TipRanks為獨立第三方，提供金融分析師的分析數據，並計算分析師推薦的平均回報率和勝率。提供的信息並非投資建議，僅供参考。本文不對評級數據和報告的完整性與準確性做出認可、聲明或保證。

TipRanks提供每位分析師的星級，分析師星級代表分析師所有推薦的過往表現，通過分析師的總勝率和平均回報率综合計算得出，星星越多，則該分析師過往表現越優異，最高爲5颗星。

分析師總勝率為近一年分析師的評級成功次數占總評級次數的比率。評级的成功與否，取決於TipRanks的虚擬投資組合是否從該股票中產生正回報。

總平均回報率為基於分析師的初始評級創建虚擬投資組合，並根據評級變化對組合進行調整，在近一年中該投資組合所獲得的回報率。

声明：本內容僅用作提供資訊及教育之目的，不構成對任何特定投資或投資策略的推薦或認可。更多信息

TD Cowen Upgrades Cardinal Health(CAH.US) to Buy Rating, Raises Target Price to $144

TD Cowen Upgrades Cardinal Health(CAH.US) to Buy Rating, Raises Target Price to $144

風險及免責聲明

聲明